IRVING, Texas, Jan. 15 /PRNewswire/ -- Caris Diagnostics, a leading provider of diagnostic services in anatomic pathology and molecular testing, today announced the hiring of another nationally renowned dermatopathologist for its Phoenix laboratory. Iftikhar “Ifty” Ahmed, M.D. has joined Caris Diagnostics to support the growing dermatopathology practice for the company.
“Dr. Ahmed has been a leader in the dermatopathology community for years, with his proven commitment to patient care, teaching, and research. We are pleased to add Dr. Ahmed to our growing team of high quality dermatopathologists at Caris Dx,” commented Gail Marcus, President and Chief Executive Officer of Caris Diagnostics. “This outstanding addition reinforces our commitment to the highest level of subspecialty expertise as we expand the scope of our services to the healthcare community.”
Dr. Ahmed joins Caris Diagnostics from the Mayo Clinic and Mayo Foundation in Rochester, MN, where he practiced for fourteen years. Most recently, he was Professor of Dermatology, Director of Dermatopathology, and Co-Director of the Dermatopathology Fellowship at the Mayo Clinic. Dr. Ahmed is board certified in Anatomic Pathology, Dermatology and Dermatopathology. He is on the editorial boards of American Journal of Dermatopathology, Dermatologic Surgery, Journal of American Academy of Dermatology, and he is Section Editor of International Journal of Dermatology. Dr. Ahmed holds the office of Vice President of the Federation for International Dermatologic Education, which provides travel and educational grants for continued education to developing countries. He has been an active lecturer at international and national meetings including the Annual Meetings of the American Society of Dermatopathology and the American Academy of Dermatology.
“The ability to attract someone of Dr. Ahmed’s stature demonstrates that our goal of providing academic-caliber medicine in a commercial setting is recognized and appreciated among the medical community,” concluded Richard H. Lash, M.D., Chief Medical Officer of Caris Diagnostics. “We have found that our dedication to providing the highest level of subspecialty diagnostics in a supportive environment that includes research and education is appealing to the finest pathologists in the country.”
About Caris Diagnostics
Caris Diagnostics is a leading provider of the highest quality diagnostic services in anatomic pathology and molecular testing. Caris Diagnostics provides world-class surgical pathology services to physicians who treat patients in an ambulatory setting. The company provides academic-caliber medical consults through its industry-leading team of subspecialty fellowship and expert-trained pathologists in gastrointestinal and liver pathology and dermatopathology. Caris Diagnostics provides the highest levels of service to its customers and their patients through its state-of-the-art laboratories; proprietary, advanced clinical and technology solutions; and rigorous quality assurance programs. Through the cutting-edge testing facilities of Caris MPI, the company also offers advanced analysis of patient samples through prognostic testing services and genomic and proteomic profiling to help guide physicians in the treatment of cancer and other complex diseases. As well, Caris MPI offers a single-source solution for biospecimen procurement, storage, tracking, analysis and reporting for research institutes, pharmaceutical and diagnostic companies and medical centers. More than 1,500 physicians nationally use Caris Diagnostics. Formed in 1996, the company is headquartered in Irving, Texas and operates four laboratories: Irving, Texas; Phoenix, Arizona (2 sites); and Newton, Massachusetts. Additional information is available at http://www.carisdx.com.
CONTACT: Leslie Brille, SVP Corporate Affairs, +1-212-521-4400, for Caris
Diagnostics
Web site: http://www.carisdx.com/
